# Ares Management Corp: financial statements, quarterly

ARES · NYSE · CIK 1176948 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ares.md) · [Financials](/companies/ares/financials.md) · [Filings](/companies/ares/filings.md) · [Insiders](/companies/ares/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ares/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [671](/filings/0001628280-24-046482.md) | [1,054 d](/filings/0001628280-26-011413.md) | [707](/filings/0001628280-25-024412.md) | [789](/filings/0001628280-25-039330.md) | [1,130](/filings/0001628280-25-049899.md) | [1,259 d](/filings/0001628280-26-011413.md) | [1,089](/filings/0001628280-26-032990.md) | [1,350](/filings/0001628280-26-054538.md) | [1,658](/filings/0001628280-25-049899.md) | [1,505 d](/filings/0001628280-26-011413.md) | [1,396](/filings/0001628280-26-032990.md) | [1,429](/filings/0001628280-26-054538.md) |
| Selling, general and administrative | $m | [212](/filings/0001628280-24-046482.md) | [159 d](/filings/0001628280-26-011413.md) | [171](/filings/0001628280-25-024412.md) | [169](/filings/0001628280-25-039330.md) | [197](/filings/0001628280-25-049899.md) | [199 d](/filings/0001628280-26-011413.md) | [228](/filings/0001628280-26-032990.md) | [232](/filings/0001628280-26-054538.md) | [246](/filings/0001628280-25-049899.md) | [290 d](/filings/0001628280-26-011413.md) | [240](/filings/0001628280-26-032990.md) | [256](/filings/0001628280-26-054538.md) |
| Interest expense | $m | [26.0](/filings/0001628280-23-036834.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [29.9](/filings/0001628280-24-046482.md) | [59.6 d](/filings/0001628280-26-011413.md) | [27.2](/filings/0001628280-25-024412.md) | [41.1](/filings/0001628280-25-039330.md) | [46.5](/filings/0001628280-25-049899.md) | [49.9 d](/filings/0001628280-26-011413.md) | [17.5](/filings/0001628280-26-032990.md) | [61.0](/filings/0001628280-26-054538.md) | [112](/filings/0001628280-25-049899.md) | [8.1 d](/filings/0001628280-26-011413.md) | [59.9](/filings/0001628280-26-032990.md) | [73.0](/filings/0001628280-26-054538.md) |
| Net income | $m | [117](/filings/0001628280-24-046482.md) | [(87.6) d](/filings/0001628280-26-011413.md) | [73.0](/filings/0001628280-25-024412.md) | [94.9](/filings/0001628280-25-039330.md) | [118](/filings/0001628280-25-049899.md) | [177 d](/filings/0001628280-26-011413.md) | [47.2](/filings/0001628280-26-032990.md) | [137](/filings/0001628280-26-054538.md) | [289](/filings/0001628280-25-049899.md) | [54.2 d](/filings/0001628280-26-011413.md) | [143](/filings/0001628280-26-032990.md) | [151](/filings/0001628280-26-054538.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [23.4](/filings/0001628280-23-036834.md) | [24.7](/filings/0001628280-25-008665.md) | [24.4](/filings/0001628280-24-021890.md) | [24.2](/filings/0001628280-24-035320.md) | [24.5](/filings/0001628280-24-046482.md) | [24.9](/filings/0001628280-26-011413.md) | [27.2](/filings/0001628280-25-024412.md) | [27.3](/filings/0001628280-25-039330.md) | [27.0](/filings/0001628280-25-049899.md) | [28.6](/filings/0001628280-26-054538.md) | [28.4](/filings/0001628280-26-032990.md) | [29.6](/filings/0001628280-26-054538.md) |
| Total liabilities | $bn | [18.3](/filings/0001628280-23-036834.md) | [19.7](/filings/0001628280-25-008665.md) | [19.4](/filings/0001628280-24-021890.md) | [18.4](/filings/0001628280-24-035320.md) | [18.6](/filings/0001628280-24-046482.md) | [17.5](/filings/0001628280-26-011413.md) | [18.4](/filings/0001628280-25-024412.md) | [18.4](/filings/0001628280-25-039330.md) | [18.4](/filings/0001628280-25-049899.md) | [19.9](/filings/0001628280-26-054538.md) | [20.0](/filings/0001628280-26-032990.md) | [21.0](/filings/0001628280-26-054538.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [1.7](/filings/0001628280-23-036834.md) | [1.9](/filings/0001628280-25-008665.md) | [1.8](/filings/0001628280-24-021890.md) | [2.0](/filings/0001628280-24-035320.md) | [2.1](/filings/0001628280-24-046482.md) | [3.5](/filings/0001628280-26-011413.md) | [4.5](/filings/0001628280-25-024412.md) | [4.4](/filings/0001628280-25-039330.md) | [4.5](/filings/0001628280-25-049899.md) | [4.3](/filings/0001628280-26-054538.md) | [4.0](/filings/0001628280-26-032990.md) | [4.0](/filings/0001628280-26-054538.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [318 d](/filings/0001628280-24-046482.md) | [(560) d](/filings/0001628280-26-011413.md) | [710](/filings/0001628280-25-024412.md) | [432 d](/filings/0001628280-25-039330.md) | [841 d](/filings/0001628280-25-049899.md) | [808 d](/filings/0001628280-26-011413.md) | [1,994](/filings/0001628280-26-032990.md) | [416 d](/filings/0001628280-26-054538.md) | [1,341 d](/filings/0001628280-25-049899.md) | [(484) d](/filings/0001628280-26-011413.md) | [407](/filings/0001628280-26-032990.md) | [(351) d](/filings/0001628280-26-054538.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | not reported | not reported | [16.3](/filings/0001628280-25-008665.md) | [16.0](/filings/0001628280-25-008665.md) | [16.2](/filings/0001628280-25-008665.md) | [16.1](/filings/0001628280-25-008665.md) | [21.5](/filings/0001628280-26-011413.md) | [21.0](/filings/0001628280-26-011413.md) | [21.1](/filings/0001628280-26-011413.md) | [21.0](/filings/0001628280-26-011413.md) | [25.4](/filings/0001628280-26-054538.md) | [25.2](/filings/0001628280-26-054538.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends

Shares outstanding: 103,332,418 at 2019-04-29, from the cover of the [10-Q filed 2019-05-06](/filings/0001628280-19-005931.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.